Get started
Author

Melek Karakurt Eryılmaz

Observed names: Eryılmaz, Melek Karakurt, Karakurt Eryılmaz, Melek, M. Karakurt Eryilmaz, M. Karakurt Eryılmaz, MELEK KARAKURT ERYILMAZ, Melek Eryilmaz, Melek K Eryılmaz, Melek K. Eryılmaz, Melek KARAKURT ERYILMAZ, Melek Karakurt, Melek Karakurt ERYILMAZ, Melek Karakurt Eryilmaz
Observed institutions: Akdeniz University, Hitit Üniversitesi, Hitit Üniversitesi Çorum Eğitim ve Araştırma Hastanesi, Necmettin Erbakan University, Akdeniz University Hospital, Konya City Hospital, Afyon Kocatepe University
ORCID: 0000-0003-2597-5931
Observed ORCID: 0000-0003-2597-5931
OpenAlex ID: A5080834334
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer
2015 · DERYA KIVRAK SALIM, HASAN MUTLU, et al. · Molecular and Clinical Oncology · 39
PDF
The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
2014 · Melek Karakurt Eryilmaz, Hasan Mutlu, et al. · Asian Pacific Journal of Cancer Prevention · 36
PDF
Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio
2023 · Mehmet Zahid Kocak, Seda Coban, et al. · Supportive Care in Cancer · 24
Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer
2016 · Fatma Yalçin Müsri, Hasan Mutlu, et al. · Journal of the Korean Gastric Cancer Association · 24
PDF
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer
2022 · Dilek Çağlayan, Mehmet Zahid Koçak, et al. · European Journal of Clinical Pharmacology · 23
PDF
Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature
2015 · Melek Karakurt Eryılmaz, Hasan Mutlu, et al. · Journal of Oncology Pharmacy Practice · 19
Molecular Types and Neoadjuvant Chemotherapy in Patients with Breast Cancer- While Molecular Shifting is More Common in Luminal a Tumors, The Pathologic Complete Response is Most Frequently Observed in Her-2 Like Tumors
2014 · Derya Kivrak Salim, Hasan Mutlu, et al. · Asian Pacific Journal of Cancer Prevention · 18
PDF
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
2023 · Mehmet Zahid Kocak, Muhiddin Er, et al. · European Journal of Clinical Pharmacology · 14
Prognostic Significance of Radiologic Extranodal Extension in Nasopharyngeal Cancer
2021 · Melek Karakurt Eryılmaz, Cengiz Kadıyoran · Otolaryngology · 13
Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature
2019 · Mustafa Karaağaç, Melek Karakurt Eryılmaz · Journal of Oncology Pharmacy Practice · 13
The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer
2019 · Tuba Karpuz, Murat Araz, et al. · Journal of Gastrointestinal Cancer · 13
Ribociclib-induced hepatotoxicity
2023 · Muhammed Muhiddin Er, Murat Araz, et al. · Journal of Oncology Pharmacy Practice · 12
Experience of bevacizumab in a patient with colorectal cancer after renal transplantation
2015 · Fatma Yalçın Müsri, Hasan Mutlu, et al. · Journal of Cancer Research and Therapeutics · 12
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023 · Çağlar Ünal, Abdulmunir Azizy, et al. · The Oncologist · 11
PDF
Vaginal metastasis in solid tumours: our four cases and review of the literature
2021 · Mustafa Korkmaz, Melek Karakurt Eryılmaz, et al. · Journal of the Egyptian National Cancer Institute · 11
PDF
The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patients
2024 · Dilek Çağlayan, Mehmet Zahid Koçak, et al. · Future Oncology · 9
PDF
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line
2024 · Mustafa Korkmaz, Melek Karakurt Eryılmaz, et al. · European Journal of Clinical Pharmacology · 9
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
2024 · Elif Şenocak Taşçı, Başak Oyan, et al. · BMC Cancer · 9
PDF
Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy
2015 · Melek Karakurt Eryılmaz, Hasan Mutlu, et al. · Journal of Oncology Pharmacy Practice · 9
Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations
2025 · Ozkan Alan, Tugba Akın Telli, et al. · Medicina · 8
PDF
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024 · Yusuf Ilhan, Gokhan Ucar, et al. · Expert Opinion on Pharmacotherapy · 8
The effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients.
2022 · Dilek Çağlayan, Mehmet Zahid Kocak, et al. · Journal of Clinical Oncology · 8
Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal Cancer
2022 · Tuba Karaçelik, Buğra Kaya, et al. · Journal of Gastrointestinal Cancer · 8
PDF
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
2022 · CİHAN EROL, ABDULLAH SAKİN, et al. · TURKISH JOURNAL OF MEDICAL SCIENCES · 8
PDF
The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort
2020 · Mustafa Karaağaç, Yasin Sezgin, et al. · Journal of Oncology Pharmacy Practice · 8
Works count: 170
Citation count: 523
H-index: 12
I10-index: 15
Year
Topic
Type